Neuropathy in Parkinson's Disease Patients with Intestinal Levodopa Infusion versus Oral Drugs

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Jugel, Constanze ^a   Ehlen, Felicitas ^a   Taskin, Birol ^a   Marzinzik, Frank ^a   Müller, Thomas ^b   Klostermann, Fabian ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b St Joseph Hospital   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CARBIDOPA PLUS LEVODOPA;

AGE; AGED; ARTICLE; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE DURATION; DISEASE SEVERITY; FEMALE; HUMAN; MALE; MEDIAN NERVE; NERVE CONDUCTION; NEUROGRAPHY; OBSERVATIONAL STUDY; PARKINSON DISEASE; PERIPHERAL NEUROPATHY; PERONEUS NERVE; POLYNEUROPATHY; PROSPECTIVE STUDY; RISK FACTOR; SEROLOGY; TIBIAL NERVE; WEIGHT REDUCTION;

ADMINISTRATION, ORAL; AGED; ANTIPARKINSON AGENTS; CARBIDOPA; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GELS; HUMANS; INFUSIONS, PARENTERAL; INTESTINES; LEVODOPA; MALE; MIDDLE AGED; PATIENT OUTCOME ASSESSMENT; POLYNEUROPATHIES; PROSPECTIVE STUDIES; WEIGHT LOSS;

EID: 84879259639     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0066639     Document Type: Article

References (20)

1. Oertel WH, Wolters E, Sampaio C, Gimenez-Roldan S, Bergamasco B, et al. (2006) Pergolide versus levodopa monotherapy in early Parkinson's disease patients: The PELMOPET study. Mov Disord 21: 343-353.
2. Nyholm D, Nilsson Remahl AI, Dizdar N, Constantinescu R, Holmberg B, et al. (2005) Duodenal levodopa infusion monotherapy vs oral polypharmacy in advanced Parkinson disease. Neurology 64: 216-223.
3. Antonini A, Isaias IU, Canesi M, Zibetti M, Mancini F, et al. (2007) Duodenal levodopa infusion for advanced Parkinson's disease: 12-month treatment outcome. Mov Disord 22: 1145-1149.
4. Devos D, French DSG, (2009) Patient profile, indications, efficacy and safety of duodenal levodopa infusion in advanced Parkinson's disease. Mov Disord 24: 993-1000.
5. Klostermann F, Jugel C, Muller T, Marzinzik F, (2012) Malnutritional neuropathy under intestinal levodopa infusion. J Neural Transm 119: 369-372.
6. Manca D, Cossu G, Murgia D, Molari A, Ferrigno P, et al. (2009) Reversible encephalopathy and axonal neuropathy in Parkinson's disease during duodopa therapy. Mov Disord 24: 2293-2294.
7. Meppelink AM, Nyman R, van Laar T, Drent M, Prins T, et al. (2011) Transcutaneous port for continuous duodenal levodopa/carbidopa administration in Parkinson's disease. Mov Disord 26: 331-334.
8. Santos-Garcia D, de la Fuente-Fernandez R, Valldeoriola F, Palasi A, Carrillo F, et al. (2012) Polyneuropathy while on duodenal levodopa infusion in Parkinson's disease patients: we must be alert. Journal of Neurology 259: 1668-1672.
9. Urban PP, Wellach I, Faiss S, Layer P, Rosenkranz T, et al. (2010) Subacute Axonal Neuropathy in Parkinson's Disease with Cobalamin and Vitamin B6 Deficiency Under Duodopa Therapy. Movement Disorders 25: 1748-1752.
10. Bril V, Tomioka S, Buchanan RA, Perkins BA, Grp mS, (2009) Reliability and validity of the modified Toronto Clinical Neuropathy Score in diabetic sensorimotor polyneuropathy. Diabetic Medicine 26: 240-246.
11. Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, et al. (2010) Systematic review of levodopa dose equivalency reporting in Parkinson's disease. Mov Disord 25: 2649-2653.
12. Bortz J (1993) Statistik für Sozialwissenschaftler. Berlin: Springer.
13. Tison F, Le Masson G, (2011) Parkinson disease, L-dopa, and neuropathy Did we miss something? Neurology 77: 1938-1939.
14. Muller T, Renger K, Kuhn W, (2004) Levodopa-associated increase of homocysteine levels and sural axonal neurodegeneration. Archives of Neurology 61: 657-660.
15. Rajabally YA, Martey J, (2011) Neuropathy in Parkinson disease Prevalence and determinants. Neurology 77: 1947-1950.
16. Toth C, Breithaupt K, Ge S, Duan Y, Terris JM, et al. (2010) Levodopa, Methylmalonic Acid, and Neuropathy in Idiopathic Parkinson Disease. Annals of Neurology 68: 28-36.
17. Toth C, Brown MS, Furtado S, Suchowersky O, Zochodne D, (2008) Neuropathy as a Potential Complication of Levodopa Use in Parkinson's Disease. Movement Disorders 23: 1850-1859.
18. Aasheim ET, Hofso D, Hjelmesaeth J, Sandbu R, (2008) Peripheral Neuropathy and Severe Malnutrition following Duodenal Switch. Obesity Surgery 18: 1640-1643.
19. Juhasz-Pocsine K, Rudnicki SA, Archer RL, Harik SI, (2007) Neurologic complications of gastric bypass surgery for morbid obesity. Neurology 68: 1843-1850.
20. Thaisetthawatkul P, Collazo-Clavell ML, Sarr MG, Norell JE, Dyck PJB, (2004) A controlled study of peripheral neuropathy after bariatric surgery. Neurology 63: 1462-1470.